Menu
Recruiting NCT06644976

Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

— Observational Osteoperosis Femoral Neck Fractures Anticoagulant Therapy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: femoral neck CRIF.
Who it may be relevant to
Registry conditions: Osteoperosis, Femoral Neck Fractures, Anticoagulant Therapy. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Israel
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery

Overview

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk

Interventions

  • Procedure femoral neck CRIF
    femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels

Primary outcome measures

  • bleeding [Time frame: 30 days]

Eligibility criteria

Inclusion criteria

above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery

\-

Exclusion criteria

  • under 18 y.o
  • anti platelet therapy (aspirin is not included)
  • creatinine clearance under 50
  • active anti cancer therapy
  • ITP patients
  • non capable of making inform consent
  • patients which decide not to proceed with the expeirment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

Israel · 1 center
  • Meir Hospital — Kfar Saba

Identifiers

NCT: NCT06644976 · mmc000723

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗